SS

Siddhant Sunil Seksaria

Director Director DIN 08329392
DIN 08329392 First appointment Jan 2019 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Siddhant Sunil Seksaria

Data last updated:

Siddhant Sunil Seksaria was a Director at Oxy Pharm Private Limited (2019) and Director at Innocare Products Private Limited (from 2019). The companies operate in Pharma.

DIN 08329392
Primary Designation Director
Industry Pharma
First Appointment 11 Jan 2019
Oldest Company Age 30 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Oxy Pharm Private Limited U24230MH1980PTC023348
Director11 Jan 20191980₹1.5 Lakh (FY 2024)Active
Innocare Products Private Limited U51505MH1996PTC102941
Director12 Jan 20191996Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Innocare Products Private Limited
Oxy Pharm Private Limited
Premium access

Shareholding and investment profile for Siddhant Sunil Seksaria

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Siddhant Sunil Seksaria

Siddhant Sunil Seksaria was first appointed on 11 Jan 2019 as Director at Oxy Pharm Private Limited.

Siddhant Sunil Seksaria held 2 earlier board appointments: Oxy Pharm Private Limited (Director, 11 Jan 2019 to 31 Oct 2019); Innocare Products Private Limited (Director, from 12 Jan 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available